Trump slaps steep tariffs on patented drug imports
The Trump administration is imposing 100% tariffs on patented pharmaceutical drug imports, with initial implementation targeting several major pharmaceutical companies on July 31 and full-scale rollout beginning in September. The measure is designed to pressure drug manufacturers to shift production to U.S.-based facilities. The scope and timeline suggest significant near-term disruption across pharmaceutical supply chains.